167 related articles for article (PubMed ID: 15876350)
1. Amplification and overexpression of the ID4 gene at 6p22.3 in bladder cancer.
Wu Q; Hoffmann MJ; Hartmann FH; Schulz WA
Mol Cancer; 2005 May; 4(1):16. PubMed ID: 15876350
[TBL] [Abstract][Full Text] [Related]
2. E2F3 is the main target gene of the 6p22 amplicon with high specificity for human bladder cancer.
Oeggerli M; Schraml P; Ruiz C; Bloch M; Novotny H; Mirlacher M; Sauter G; Simon R
Oncogene; 2006 Oct; 25(49):6538-43. PubMed ID: 16953223
[TBL] [Abstract][Full Text] [Related]
3. Expression analysis of 6p22 genomic gain in retinoblastoma.
Orlic M; Spencer CE; Wang L; Gallie BL
Genes Chromosomes Cancer; 2006 Jan; 45(1):72-82. PubMed ID: 16180235
[TBL] [Abstract][Full Text] [Related]
4. 6p22.3 amplification as a biomarker and potential therapeutic target of advanced stage bladder cancer.
Shen H; Morrison CD; Zhang J; Underwood W; Yang N; Frangou C; Eng K; Head K; Bollag RJ; Kavuri SK; Rojiani AM; Li Y; Yan L; Hill A; Woloszynska-Read A; Wang J; Liu S; Trump DL; Candace JS
Oncotarget; 2013 Nov; 4(11):2124-34. PubMed ID: 24231253
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of potential target genes of the 6p22.3-amplicon in urinary bladder cancer].
Oeggerli M; Schraml P; Novotny H; Sauter G; Simon R
Verh Dtsch Ges Pathol; 2005; 89():219-24. PubMed ID: 18035695
[TBL] [Abstract][Full Text] [Related]
6. Defining a 0.5-mb region of genomic gain on chromosome 6p22 in bladder cancer by quantitative-multiplex polymerase chain reaction.
Evans AJ; Gallie BL; Jewett MA; Pond GR; Vandezande K; Underwood J; Fradet Y; Lim G; Marrano P; Zielenska M; Squire JA
Am J Pathol; 2004 Jan; 164(1):285-93. PubMed ID: 14695341
[TBL] [Abstract][Full Text] [Related]
7. E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer.
Oeggerli M; Tomovska S; Schraml P; Calvano-Forte D; Schafroth S; Simon R; Gasser T; Mihatsch MJ; Sauter G
Oncogene; 2004 Jul; 23(33):5616-23. PubMed ID: 15122326
[TBL] [Abstract][Full Text] [Related]
8. Amplification and overexpression of E2F3 in human bladder cancer.
Feber A; Clark J; Goodwin G; Dodson AR; Smith PH; Fletcher A; Edwards S; Flohr P; Falconer A; Roe T; Kovacs G; Dennis N; Fisher C; Wooster R; Huddart R; Foster CS; Cooper CS
Oncogene; 2004 Feb; 23(8):1627-30. PubMed ID: 14716298
[TBL] [Abstract][Full Text] [Related]
9. Expression of bcl-2 and bcl-X in bladder cancer.
Kirsh EJ; Baunoch DA; Stadler WM
J Urol; 1998 Apr; 159(4):1348-53. PubMed ID: 9507882
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification.
Hurst CD; Tomlinson DC; Williams SV; Platt FM; Knowles MA
Oncogene; 2008 Apr; 27(19):2716-27. PubMed ID: 18037967
[TBL] [Abstract][Full Text] [Related]
11. The SRY-HMG box gene, SOX4, is a target of gene amplification at chromosome 6p in lung cancer.
Medina PP; Castillo SD; Blanco S; Sanz-Garcia M; Largo C; Alvarez S; Yokota J; Gonzalez-Neira A; Benitez J; Clevers HC; Cigudosa JC; Lazo PA; Sanchez-Cespedes M
Hum Mol Genet; 2009 Apr; 18(7):1343-52. PubMed ID: 19153074
[TBL] [Abstract][Full Text] [Related]
12. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
Simonetti S; Russo R; Ciancia G; Altieri V; De Rosa G; Insabato L
Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884
[TBL] [Abstract][Full Text] [Related]
13. Id4 is deregulated by a t(6;14)(p22;q32) chromosomal translocation in a B-cell lineage acute lymphoblastic leukemia.
Bellido M; Aventín A; Lasa A; Estivill C; Carnicer MJ; Pons C; Matías-Guiu X; Bordes R; Baiget M; Sierra J; Nomdedéu JF
Haematologica; 2003 Sep; 88(9):994-1001. PubMed ID: 12969807
[TBL] [Abstract][Full Text] [Related]
14. Stem-Like Signature Predicting Disease Progression in Early Stage Bladder Cancer. The Role of E2F3 and SOX4.
Bellmunt J
Biomedicines; 2018 Aug; 6(3):. PubMed ID: 30072631
[TBL] [Abstract][Full Text] [Related]
15. HER-2/neu protein overexpression and gene amplification in human transitional cell carcinoma of the bladder.
Coogan CL; Estrada CR; Kapur S; Bloom KJ
Urology; 2004 Apr; 63(4):786-90. PubMed ID: 15072912
[TBL] [Abstract][Full Text] [Related]
16. Is quantitative real-time RT-PCR an adjunct to immunohistochemistry for the evaluation of ErbB2 status in transitional carcinoma of the bladder?
Amsellem-Ouazana D; Bièche I; Molinié V; Elie C; Vieillefond A; Tozlu S; Botto H; Debré B; Lidereau R
Eur Urol; 2006 Jun; 49(6):1035-42; discussion 1042-3. PubMed ID: 16466848
[TBL] [Abstract][Full Text] [Related]
17. High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer.
Zaharieva BM; Simon R; Diener PA; Ackermann D; Maurer R; Alund G; Knönagel H; Rist M; Wilber K; Hering F; Schönenberger A; Flury R; Jäger P; Fehr JL; Mihatsch MJ; Gasser T; Sauter G; Toncheva DI
J Pathol; 2003 Dec; 201(4):603-8. PubMed ID: 14648664
[TBL] [Abstract][Full Text] [Related]
18. Delineation of the 6p22 amplification unit in urinary bladder carcinoma cell lines.
Bruch J; Schulz WA; Häussler J; Melzner I; Brüderlein S; Möller P; Kemmerling R; Vogel W; Hameister H
Cancer Res; 2000 Aug; 60(16):4526-30. PubMed ID: 10969802
[TBL] [Abstract][Full Text] [Related]
19. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression.
Quentin T; Henke C; Korabiowska M; Schlott T; Zimmerman B; Kunze E
Anticancer Res; 2004; 24(2B):1011-23. PubMed ID: 15161057
[TBL] [Abstract][Full Text] [Related]
20. ERBB2 amplifications in esophageal adenocarcinoma.
Dahlberg PS; Jacobson BA; Dahal G; Fink JM; Kratzke RA; Maddaus MA; Ferrin LJ
Ann Thorac Surg; 2004 Nov; 78(5):1790-800. PubMed ID: 15511476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
